NEW
Arexvy

Arexvy Description

respiratory syncytial virus vaccine

Manufacturer:

GlaxoSmithKline

Distributor:

Zuellig
The information highlighted (if any) are the most recent updates for this brand.
Full Prescribing Info
Description
The powder is white. The suspension is an opalescent, colourless to pale brownish liquid.
After reconstitution, one dose (0.5 mL) contains: RSVPreF31 antigen2,3 120 micrograms.
1 Respiratory Syncytial Virus recombinant glycoprotein F stabilised in the pre-fusion conformation = RSVPreF3.
2 RSVPreF3 produced in Chinese Hamster Ovary (CHO) cells by recombinant DNA technology.
3 adjuvanted with AS01E containing: plant extract Quillaja saponaria Molina, fraction 21 (QS-21) 25 micrograms; 3-O-desacyl-4'-monophosphoryl lipid A (MPL) from Salmonella minnesota 25 micrograms.
Excipients/Inactive Ingredients: Powder (RSVPreF3 antigen): Trehalose dihydrate, Polysorbate 80 (E 433), Potassium dihydrogen phosphate (E 340), Dipotassium phosphate (E 340).
Suspension (AS01E Adjuvant System): Dioleoyl phosphatidylcholine (E 322), Cholesterol, Sodium chloride, Anhydrous disodium phosphate (E 339), Potassium dihydrogen phosphate (E 340), Water for injections.
Exclusive offer for doctors
Register for a MIMS account and receive free medical publications worth $768 a year.
Already a member? Sign in